Oxford Gene Technology

Powerful, flexible and easy-to-use analysis solution gets the most out of NGS data

Researchers can now access the high-quality results of hybridisation-based targeted sequencing with a speed comparable to that of amplicon-based approaches

New SureSeq myPanel NGS Custom Cancer Panel content covers a wider range of cancer types with excellent coverage uniformity for confident results

SureSeq myPanel NGS Custom FH Panels enable streamlined investigation of FH and customisation of content

Oxford Gene Technology has today announced a significant expansion of its existing catalogue of Cytocell Aquarius Haematology probes for fluorescence in situ hybridisation

SureSeq myPanel NGS Custom Cancer Panels enable researchers to create bespoke probe panels from an expert-curated library

Oxford Gene Technology has launched two new CE-IVD labelled fluorescence in situ hybridisation (FISH) probes

Leading cancer researchers to speak Oxford Gene Technology seminar

Confident genome-wide aneuploidy detection in 14 samples on a single array from Oxford Gene Technology

Oxford Gene Technology expands its range of research-validated CytoSure Molecular Arrays to investigate DNA

Source BioScience has acquired the next-generation sequencing services business from Oxford Gene Technology